FDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024Psoriatic ArthritisPsoriasis
FDA Approves Cosibelimab for Cutaneous SCCDecember 17, 2024Nonmelanoma Skin CancerBusiness of Medicine
New Cause of Sexually Transmitted Fungal Infection Reported in MSMNovember 13, 2024Infectious Diseases
Bimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024Psoriatic ArthritisPsoriasis
FDA OKs Subcutaneous Atezolizumab Formulation for Multiple Cancer IndicationsSeptember 17, 2024Mixed TopicsMelanoma
FDA Approves First Engineered Cell Therapy for a Solid TumorAugust 2, 2024Nonmelanoma Skin CancerRare DiseasesMelanomaBusiness of Medicine
Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatricsRare DiseasesPsoriasis
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024MelanomaNonmelanoma Skin Cancer
Belimumab Autoinjector Approved for Pediatric LupusMay 22, 2024PediatricsRare DiseasesAutoimmune Diseases
Measles Control So Far in 2024: ‘Not Off to a Great Start’March 25, 2024Infectious DiseasesPediatrics
TIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?March 8, 2024MelanomaBusiness of MedicineMixed Topics
Omalizumab for Food Allergies: What PCPs Should KnowMarch 4, 2024UrticariaAtopic DermatitisPediatrics
